News Research Diagnostics & Imaging Research and Evidence Precision Endocrinology

Agentic AI system may improve rare disease diagnosis 

Higher diagnostic accuracy seen in endocrine system disorders and multisystem conditions. 

April 07, 2026 By Matthew Solan 3 min read
Share

5 Key Takeaways

  • 1

    DeepRare, an AI system, improved diagnostic accuracy for rare diseases compared to existing tools and physicians.

  • 2

    The system integrates over 40 tools and databases, providing evidence-based reasoning to enhance diagnostic efficiency.

  • 3

    DeepRare achieved higher Recall@1 scores than comparator models, with 69.1% for phenotype and genetic data tasks.

  • 4

    In direct comparisons, DeepRare outperformed experienced physicians, achieving 64% Recall@1 versus 55%.

  • 5

    The system is designed for patients suspected of rare diseases, not for general screening, with noted limitations.

AACE Endocrine AI is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE®). The ideas and opinions expressed in AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies.

Related Content